Immunome (NASDAQ:IMNM) Azioni

IMMUNOME INC

Immunome

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Immunome Inc

WIIM

ZM stock has given up its prior gain. Zoom shares were trading higher after the company reported better-than-expected Q1 earnings and issued upbeat guidance.

<a href="https://www.bloomberg.com/news/articles/2025-05-21/pfizer-hits-fda-setback-in-effort-to-boost-prostate-cancer-drug?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-21/pfizer-hits-fda-setback-in-effort-to-boost-prostate-cancer-drug?embedded-checkout=true</a>

News

General

'Pfizer Hits FDA Setback in Effort to Boost Prostate Cancer Drug'- Bloomberg

<a href="https://www.theinformation.com/articles/nike-sell-amazon-first-time-since-2019">https://www.theinformation.com/articles/nike-sell-amazon-first-time-since-2019</a>

AMZN

'Nike to Sell to Amazon For First Time Since 2019'- The Information

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) has outperformed the market over the past 5 years by 15.52% on an annualized basis producing an average annual return of 29.8%. Currently, Parker Hannifin has a market capitalization of $85.21 billion. 
Buying $1000 In PH: If an investor had bought $1000 of PH stock 5 years ago, it would be worth $3,684.13 today based on a price of $661.78 for PH at the time of writing.
<h3>Parker Hannifin's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747862131_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $1000 Invested In Parker Hannifin 5 Years Ago Would Be Worth Today

LAZR

Luminar Receives $200M  Capital Commitment to Bolster Balance Sheet & Liquidity

Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) shares were up nearly 2% on Wednesday before pulling back as the broader market turned lower. Here&#8217;s a look <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45550679/treasury-yields-top-5-these-20-stocks-tanked-in-just-one-hour">at what happened</a>.
What To Know: During an interview aired on CNBC's "Closing Bell: Overtime" on Tuesday, Elon Musk stated that Tesla and xAI will continue purchasing "a lot" of GPUs from both Nvidia and AMD, as long as they outperform in-house chip efforts. 
He highlighted xAI's Memphis-based training cluster powered by over 200,000 GPUs and confirmed plans to build a new facility housing one million Nvidia Blackwell GPUs.
The news <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45531583/amd-nvidia-shares-jump-after-musk-highlights-xais-gpu-needs-we-expect-to-still-buy-a-lot">caused a spike</a> in shares of the chip stocks after hours, which carried into Wednesday&#8217;s trading session. 
Separately, AMD announced a lineup of new hardware at Computex 2025, which appeared to spur buying activity in AMD shares. 
The company <a href="https://www.benzinga.com/tech/25/05/45542185/amd-unveils-powerful-new-ai-gaming-chips-at-computex-to-challenge-nvidia">introduced</a> its Radeon RX 9060 XT and Radeon AI PRO R9700 GPUs, built on the RDNA 4 architecture, with a focus on 1440p gaming, AI inference and workstation applications. AMD also launched the Ryzen Threadripper 9000 and 9000 WX-Series processors, aimed at high-end desktops and professional use cases.
Despite the bullish momentum, AMD stock rolled over with the broader market Wednesday afternoon after a<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45550679/treasury-yields-top-5-these-20-stocks-tanked-in-just-one-hour"> weak 20-year bond auction</a> led to a spike in Treasury yields above 5.08%. Traders also appeared to react to a new budget bill that could worsen the U.S. deficit. 
AMD Price Action: Despite the strong move in AMD shares to start the day, the stock tumbled in afternoon trading and closed Wednesday&#8217;s session down 1.28% at $112.06, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45551302/5-undervalued-stocks-to-buy-on-china-tariff-cuts">5 Undervalued Stocks To Buy On China Tariff Cuts</a></li>
</ul>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45550679/treasury-yields-top-5-these-20-stocks-tanked-in-just-one-hour">Treasury Yields Top 5%: These 20 Stocks Tanked In Just One Hour </a></li>
</ul>
Image via Shutterstock.

Movers

What Happened To AMD Stock Today?

<a href="https://www.wsj.com/business/media/nbcuniversal-bids-for-mlb-rights-espn-dropped-a98e16c5?msockid=21c662101c496b42343370ae1de86aaa">https://www.wsj.com/business/media/nbcuniversal-bids-for-mlb-rights-espn-dropped-a98e16c5?msockid=21c662101c496b42343370ae1de86aaa</a>

CMCSA

'NBCUniversal Bids for MLB Rights ESPN Dropped'- WSJ

Management

FANG

Diamondback Energy Travis D. Stice To Step Down As Chief Executive Officer; Kaes Van't Hof To Become New CEO, Effective May 21, 2025

Navitas Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) shares are rocketing higher in after-hours trading Wednesday after the company was selected by NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) to collaborate on next-generation <a href="https://www.benzinga.com/pressreleases/25/05/g45552649/nvidia-selects-navitas-to-collaborate-on-next-generation-800-v-hvdc-architecture">800 V HVDC architecture</a>.
What Happened: After the market close on Wednesday, Navitas announced a collaboration with Nvidia to support Kyber rack-scale systems powering the company&#8217;s GPUs. Nvidia&#8217;s 800V HVDC architecture is focused on high-efficiency, scalable power delivery for next-generation AI workloads.
&#8220;We are proud to be selected by Nvidia to collaborate on their 800 HVDC architecture initiative. Our latest innovations in high-power GaN and SiC technologies have seen world firsts and have created new inflections into markets such as AI datacenters and electric vehicles,&#8221; said Gene Sheridan, co-founder and CEO of Navitas.
&#8220;With our wide portfolio range, we can support NVIDIA&#8217;s 800V HVDC infrastructure, from grid to the GPU.&#8221;
The 800V HVDC directly powers the IT racks and is converted by DC-DC converters to lower voltages, which is expected to drive GPUs, such as the Rubin Ultra. Nvidia&#8217;s 800V HVDC architecture is expected to improve end-to-end power efficiency up to&nbsp;5%, reduce maintenance costs by&nbsp;70% and lower cooling costs.
<h1 class="wp-block-heading">How To Buy NVTS Stock</h1>
By now you're likely curious about how to participate in the market for Navitas — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading — either way, it allows you to profit off of the share price decline.
NVTS Price Action: <a href="http://benzinga.com/quote/nvts">Navitas Semiconductor shares</a> were up 224.08% after hours, trading at $6.19 at the time of publication on Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/large-cap/25/05/45524565/nvidias-1-trillion-comeback-shows-deepseek-no-longer-spooks-wall-street">Nvidia&#8217;s $1 Trillion Comeback Shows DeepSeek No Longer Spooks Wall Street</a></li>
</ul>
Photo: Shutterstock.

After-Hours Center

Tech

NVDA

NVTS

Navitas Semiconductor Shares Soar On Nvidia Collaboration

RAMP

RAMP stock has given up its prior loss. LiveRamp Holdings shares were trading lower following Q4 financial results.

Guidance

Pitney Bowes Reaffirms Full-Year Financial Guidance Due to the Continued Strength of SendTech and Presort

<h3>Gainers</h3>
<ul>
<li>Star Equity Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRR#NASDAQ">STRR</a>) stock increased by 24.5% to $2.74 during Wednesday's after-market session. The market value of their outstanding shares is at $8.7 million. </li>
<li>Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) shares increased by 9.07% to $65.01. The market value of their outstanding shares is at $6.0 billion. As per the press release, Q1 earnings came out today. </li>
<li>Jinxin Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMI#NASDAQ">NAMI</a>) stock increased by 7.14% to $3.3. The company's market cap stands at $225.6 million. </li>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) shares rose 5.65% to $2.99. The market value of their outstanding shares is at $22.2 million. </li>
<li>Top Win International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOPW#NASDAQ">TOPW</a>) shares rose 5.28% to $9.3. The market value of their outstanding shares is at $231.2 million. </li>
<li>Newegg Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) stock moved upwards by 5.26% to $6.01. The company's market cap stands at $117.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lottery.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) stock fell 8.4% to $1.63 during Wednesday's after-market session. The company's market cap stands at $30.7 million. As per the press release, Q1 earnings came out today. </li>
<li>MKDWell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKDW#NASDAQ">MKDW</a>) stock decreased by 7.67% to $0.3. The company's market cap stands at $43.0 million. </li>
<li>U Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCAR#NASDAQ">UCAR</a>) shares decreased by 7.47% to $2.85. The market value of their outstanding shares is at $12.0 million. </li>
<li>Ollie's Bargain Outlet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) shares fell 5.0% to $110.53. The market value of their outstanding shares is at $6.7 billion. </li>
<li>JX Luxventure Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXG#NASDAQ">JXG</a>) shares fell 4.75% to $2.41. The company's market cap stands at $3.6 million. As per the press release, FY earnings came out 4 days ago. </li>
<li>J-Long Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JL#NASDAQ">JL</a>) shares fell 4.67% to $4.5. The market value of their outstanding shares is at $14.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALUR

LTRY

MKDW

NAMI

NEGG

OLLI

STRR

TOPW

UCAR

URBN

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Longevity Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) shares moved upwards by 55.5% to $4.76 during Wednesday's after-market session. The market value of their outstanding shares is at $4.7 million. </li>
<li>SAB Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABS#NASDAQ">SABS</a>) shares moved upwards by 15.94% to $2.0. The market value of their outstanding shares is at $18.5 million. </li>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) stock rose 9.3% to $0.53. The market value of their outstanding shares is at $6.0 million. </li>
<li>Lipella Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) shares rose 7.26% to $3.1. The company's market cap stands at $13.8 million. </li>
<li>Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) stock moved upwards by 7.2% to $1.99. The market value of their outstanding shares is at $2.9 million. </li>
<li>Immutep (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) stock moved upwards by 6.7% to $2.07. The market value of their outstanding shares is at $301.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) shares decreased by 37.0% to $0.04 during Wednesday's after-market session. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) stock declined by 20.4% to $3.59. The company's market cap stands at $326.8 million. The company's, Q2 earnings came out 4 days ago. </li>
<li>Brainstorm Cell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCLI#NASDAQ">BCLI</a>) shares decreased by 12.72% to $1.03. The market value of their outstanding shares is at $5.8 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock fell 12.26% to $0.27. The company's market cap stands at $2.9 million. </li>
<li>BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) stock decreased by 7.02% to $0.36. The market value of their outstanding shares is at $21.0 million. </li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) shares decreased by 6.76% to $0.37. The market value of their outstanding shares is at $53.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEON

BCAB

BCLI

BDSX

BJDX

IMMP

LIPO

PTPI

SABS

VTAK

Longevity Health Holdings, Inc. - Common Stock

XAGE

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Webus International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETO#NASDAQ">WETO</a>) shares moved upwards by 17.7% to $2.79 during Wednesday's after-market session. The market value of their outstanding shares is at $61.3 million. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) stock moved upwards by 8.76% to $3.1. The company's market cap stands at $105.7 million. </li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) stock increased by 8.74% to $0.65. The market value of their outstanding shares is at $3.9 million. </li>
<li>American Superconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSC#NASDAQ">AMSC</a>) shares rose 7.56% to $26.02. The market value of their outstanding shares is at $1.0 billion. The company's, Q4 earnings came out today. </li>
<li>CPI Aerostructures (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVU#AMEX">CVU</a>) shares rose 7.26% to $3.1. The market value of their outstanding shares is at $40.3 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) shares moved upwards by 5.9% to $0.35. The company's market cap stands at $9.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) shares decreased by 10.7% to $0.15 during Wednesday's after-market session. The company's market cap stands at $4.4 million. </li>
<li>Founder Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGL#NASDAQ">FGL</a>) shares decreased by 5.89% to $0.91. The company's market cap stands at $15.3 million. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) shares fell 5.56% to $2.04. The company's market cap stands at $71.1 million. </li>
<li>Intercont (Cayman) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCT#NASDAQ">NCT</a>) shares declined by 5.35% to $4.78. The company's market cap stands at $129.2 million. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares fell 5.01% to $0.47. The market value of their outstanding shares is at $14.9 million. The company's, Q3 earnings came out 4 days ago. </li>
<li>Centuri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRI#NYSE">CTRI</a>) shares declined by 4.26% to $17.61. The market value of their outstanding shares is at $1.5 billion. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMSC

ATXG

CTRI

HTOO

MCRP

NEOV

VSTE

WETO

12 Industrials Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) stock moved upwards by 238.2% to $6.46 during Wednesday's after-market session. The company's market cap stands at $1.2 billion. </li>
<li>LiveRamp Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RAMP#NYSE">RAMP</a>) shares rose 10.01% to $30.88. The market value of their outstanding shares is at $2.0 billion. The company's, Q4 earnings came out today. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) shares increased by 9.05% to $0.59. The market value of their outstanding shares is at $1.1 million. As per the press release, Q1 earnings came out 4 days ago. </li>
<li>Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) shares rose 6.39% to $190.57. The company's market cap stands at $63.6 billion. The company's, Q1 earnings came out today. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) shares moved upwards by 5.88% to $1.08. The company's market cap stands at $27.2 million. </li>
<li>Perfect (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PERF#NYSE">PERF</a>) shares increased by 5.58% to $1.89. The market value of their outstanding shares is at $192.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) stock fell 9.4% to $1.16 during Wednesday's after-market session. The market value of their outstanding shares is at $180.5 million. </li>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) stock fell 6.25% to $0.45. The market value of their outstanding shares is at $11.6 million. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>WISeKey Intl Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKEY#NASDAQ">WKEY</a>) stock decreased by 5.14% to $6.18. The market value of their outstanding shares is at $69.3 million. </li>
<li>LightPath Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTH#NASDAQ">LPTH</a>) stock declined by 4.73% to $2.22. The company's market cap stands at $93.5 million. The company's, Q3 earnings came out 4 days ago. </li>
<li>Eastman Kodak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) stock fell 4.1% to $5.85. The company's market cap stands at $472.6 million. </li>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) shares fell 3.92% to $1.26. The market value of their outstanding shares is at $26.5 million. As per the news, the Q3 earnings report came out 4 days ago. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLRO

KODK

LPTH

PERF

SNOW

VRAR

WKEY

WOLF

12 Information Technology Stocks Moving In Wednesday's After-Market Session

Pitney Bowes Intends to Execute the Full $150M Share Repurchase Authorization in 2025

Pitney Bowes Appoints Kurt Wolf As Chief Executive Officer, Effective Immediately

<a href="https://www.wsj.com/business/retail/walmart-layoffs-reorganization-2abd46eb">https://www.wsj.com/business/retail/walmart-layoffs-reorganization-2abd46eb</a>

'Walmart to Cut 1,500 Jobs'- WSJ

Across the recent three months, 12 analysts have shared their insights on Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>), expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Fiserv, revealing an average target of $234.92, a high estimate of $268.00, and a low estimate of $194.00. A decline of 6.59% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1747861271_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Fiserv among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vasundhara Govil</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$200.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Will Nance</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$194.00</td>
<td>$223.00</td>
</tr>
<tr>
<td>Tien-Tsin Huang</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$210.00</td>
<td>$211.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$230.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$240.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Ole Slorer</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$268.00</td>
<td>$267.00</td>
</tr>
<tr>
<td>Vasundhara Govil</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$240.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Timothy Chiodo</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$255.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Ashwin Shirvaikar</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$240.00</td>
<td>$267.00</td>
</tr>
<tr>
<td>Rufus Hone</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$232.00</td>
<td>$254.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$250.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Will Nance</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$260.00</td>
<td>$246.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Fiserv. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Fiserv compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
For valuable insights into Fiserv's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Fiserv analyst ratings.</a>
<h2>Discovering Fiserv: A Closer Look</h2>
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Through the merger with First Data in 2019, Fiserv also provides payment processing services for merchants. About 10% of the company's revenue is generated internationally.
<h3>Financial Insights: Fiserv</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Positive Revenue Trend: Examining Fiserv's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.06% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 16.59%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Fiserv's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.21%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Fiserv's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.08%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Fiserv's debt-to-equity ratio is below the industry average at 1.1, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

12 Analysts Have This To Say About Fiserv

United Maritime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEA#NASDAQ">USEA</a>) will release its quarterly earnings report on Thursday, 2025-05-22. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate United Maritime to report an earnings per share (EPS) of $-0.53.
The announcement from United Maritime is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings Track Record</h3>
The company's EPS beat by $0.33 in the last quarter, leading to a 0.0% drop in the share price on the following day.
Here's a look at United Maritime's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.41</td>
<td>-0.12</td>
<td></td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.08</td>
<td>-0.03</td>
<td>0.09</td>
<td>-0.13</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>-1.0%</td>
<td>0.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<h3>Tracking United Maritime's Stock Performance</h3>
Shares of United Maritime were trading at $1.34 as of May 20. Over the last 52-week period, shares are down 52.01%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/USEA/earnings">To track all earnings releases for United Maritime visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

USEA

A Look at United Maritime's Upcoming Earnings Report

Press Releases

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aro Biotherapeutics Announces Leadership Transition and Appoints Purnanand Sarma, Ph.D., as Chief Executive Officer

Immunome to Present at Upcoming March Conferences

Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC

Immunome Reports Full Year 2024 Financial Results and Provides Business Update

Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference

Immunome Reports First Quarter 2025 Financial Results and Provides Business Update

Comments

Immunome

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO